This study aimed to identify yeasts from the gastrointestinal tract of scarlet ibises (Eudocimus ruber) and from plant material collected from the environment where they live. Then, the isolates phenotypically identified as Candida famata were submitted to molecular identification of their closely related species and evaluated for their antifungal susceptibility and possible resistance mechanisms to antifungal drugs. Cloacal swabs from 20 scarlet ibises kept in captivity at Mangal das Garç as Park (Brazil) 
Introduction
The Scarlet ibis (Eudocimus ruber) is a wading bird that inhabits coastal and mangrove areas. Few studies on this bird species have been published, mostly approaching behavioral and reproductive habits, with a lack of knowledge on the sanitary aspects of these animals. The study of the fungal microbiota of clinically healthy wild birds is an important step to understanding the epidemiology of fungal diseases. It is important to emphasize that birds may harbor potentially pathogenic yeasts in their cloaca and are capable of disseminating these fungi in the environment, which may be a problem, particularly, when these animals are raised in collective enclosures. Finally, this environmental dissemination of microorganisms may favor the occurrence of fungal infections in humans and other animals. 1, 2 Several yeast species have been isolated from the gastrointestinal tract and feces of free-ranging and captive wild birds, with emphasis on the genus Candida.
1-3 C. albicans, C. tropicalis, C. famata, C. parapsilosis, C. guilliermondii, among others, have been recovered from healthy birds, as part of the microbiota of the digestive tract of several species such as pigeons, turkeys, raptors, migratory birds and poultry. [1] [2] [3] [4] [5] Usually, these microorganisms are not harmful to the host, but they can become pathogenic, when physical, chemical, and immunological barriers are disrupted. [6] [7] [8] [9] In recent years, an increase in reports of infections caused by these yeasts has been reported, compromising several animal species, with different clinical manifestations. 3, 6, 10 The present study aimed to isolate yeasts from cloacal and stool samples of captive scarlet ibises (E. ruber) and from plant material obtained from the environment where they live. Then, the isolates phenotypically identified as Candida famata were submitted to molecular identification of their closely related species and evaluated for their antifungal susceptibility to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole through broth microdilution and the automated method VITEK 2 TM . Furthermore, possible resistance mechanisms to antifungal drugs were assessed.
Material and methods

Ethics
This research was approved by the Authorization and Information System for Biodiversity (SISBIO) of the Chico Mendes Institute for Conservation of Biodiversity (ICMBio, Brazil), under license no. 45009-1, and the Ethics Committee for the Use of Animals (CEUA) of the State University of Ceará, under the protocol number 4797437/2014.
Animal handling
For the isolation of microorganisms, cloacal and stool samples were collected from scarlet ibises (E. ruber) kept captivity at Mangal das Garças Park, in Belém, State of Pará, Brazil (S 1
• 27 51.9 ; W 48 • 30 19.9 ). All animals were clinically evaluated, and their body scores were assessed by palpating the pectoral muscle. Then, the animals were classified as obese, normal, or thin. 11 Sick animals or those classified as obese or thin were not included in this study. Two sample collections were carried out with an interval of 1 month between them. In each collection, 10 animals (20 animals in total) were randomly captured with pole nets. These animals were kept in three enclosures. In the collective enclosure of Aningas (Sector 1), scarlet ibises cohabit with other species and are fed with fish and extruded commercial bird feed, for aquatic birds, which does not contain antibacterial or antifungal drugs. On the island of scarlet ibises (Sector 2), scarlet ibises live in semifreedom along with other bird species, and they receive only extruded feed. In the extra sector (Sector 3), where the surplus scarlet ibises of the Park intended for exchange with other zoos are kept, the birds receive only extruded feed. All three enclosures had a water tank/ponds and a proper ambiance to provide well-being and stimulate reproduction and nesting. All animals were daily assisted by a veterinarian and a biologist.
Collection of biological material
The biological material from the cloaca of scarlet ibises was collected with sterile cotton swabs, which were inserted and rotated 180 degrees twice. 3 Afterward, the swabs were placed in Cary Blair transport medium, widely used for the transport and preservation of stool specimens for microbiological processing. 12 A pool of dry stool samples found where the birds were grouped was also collected, through scraping with a sterile scalpel blade and were stored in sterile sample cups. 13 
Collection of plant material
Tree hollows and trunks were scraped with a previously disinfected (70% alcohol) metal spatula, and the collected material was stored in sterile Falcon tubes. 14 
Sample processing
Cloacal and fecal samples were kept under refrigeration and transported in a thermal styrofoam box to the Specialized Medical Mycology Center of the Federal University of Ceará for microbiological processing, within 24 hours after sampling. Swabs containing cloacal material were transferred to tubes with 1 ml of sterile saline (0.9% NaCl), homogenized by vortexing for 3 minutes and left to decant for 30 minutes at room temperature. 13 The dried stool samples were initially weighed and hydrated with sterile saline (0.9% NaCl), according to the ratio of 1 g of feces for 10 ml of saline. Subsequently, the material was vortexed for 3 minutes and left to decant for 30 minutes, at room temperature. 13 For the processing of the plant material, approximately 5 g of each sample was suspended in 45 ml of saline (0.9% NaCl) containing chloramphenicol (0.05 mg/ml). This suspension was vortexed for 10 minutes and then allowed to decant for 1 hour. Subsequently, the supernatant was aspirated with a Pasteur pipette and transferred to a sterile Falcon tube.
Then, 0.1-ml aliquots of each sample (cloacal swabs, stool, and plant) were seeded in Petri dishes containing birdseed (Guizotia abyssinica) agar and Sabouraud dextrose agar supplemented with chloramphenicol (0.05 g/l) and incubated at 28
• C, for 10 days.
Isolation and identification
The plates were daily evaluated by observing the macroscopic characteristics of the colony such as aspect, elevation, texture, and color, after 48 hours of growth. Colonies suggestive of Candida spp. were subcultured on chromogenic medium (HiCrome Candida Differential Agar, HiMedia, Mumbai, India) for the identification of mixed colonies. Each isolated pure colony was submitted to biochemical tests, including carbohydrate and nitrogen assimilation and urease production on Christensen's urea agar, followed by micromorphological analyses on cornmeal-Tween-80 agar. 2, 3, 27 The tests were interpreted, in order to identify the recovered yeast species. 15, 16 Restriction fragment length polymorphism assay was performed in order to differentiate and identify the isolates phenotypically identified as C. famata. For this purpose, DNA extraction was performed using the High Pure PCR Template Preparation Kit R (Roche Applied Science Kit, Germany). Initially, conventional polymerase chain reaction (PCR) was performed using the primers ITS2F (5 -GATGTATTAGGTTTATCCAACTCGT -3 ) and 26SR (5 -TCATTTCAACCCCAATACCTC -3 ). 17 Cycling conditions included initial denaturation at 94
• C for 5 min, then 30 cycles at 94
• C for 30 s, 58
• C for 30 s, and 72
• C for 50 s, with a final extension step at 72
• C for 8 min. Subsequently, electrophoresis was performed on 2% agarose gel. Bands with molecular weight of 1.1 kb were compatible with C. famata. 17 Afterward, C. famata amplicons were subjected to double digestion with the enzymes BsaHI and XbaI (TermoLab, Lithuania), according to the manufacturer's instructions, and incubated in water bath at 37
• C for up to 16 h. Finally, electrophoresis was performed on 3% agarose gel and interpretation of the results was made according to the band size and number of restriction sites. The cryptic species of C. famata were classified according to the following digestive patterns: C. famata (three bands; 447 bp, 375 bp, and 290 bp), Debaryomyces nepalensis (four bands; 447 bp, 375 bp, 214 bp, and 76 bp) and C. palmioleophila (two bands; 660 bp and 446 bp).
17
In vitro susceptibility testing through broth microdilution
Isolates phenotypically identified as Candida famata were subjected to antifungal susceptibility testing through broth microdilution, according to the document M27-A3 of the Clinical Laboratory Standards Institute. The strains C. parapsilosis ATCC 22019 and C. krusei ATCC 6258 were used as a quality control for each performed assay. 18 The following drugs were tested: amphotericin B, fluconazole, itraconazole, voriconazole, and caspofungin. The plates were incubated at 35
• C, and they were read after 24
and 48 h. The minimal inhibitory concentration (MIC) for caspofungin, voriconazole, and fluconazole was defined as the lowest concentration able to inhibit 50% of fungal growth, when compared to drug-free control. For amphotericin B, the MIC was defined as the lowest concentration capable of inhibiting 100% of fungal growth. MIC values were interpreted according to the document M27-A3. 18 Automated susceptibility testing through VITEK 2 TM system
Isolates phenotypically identified as C. famata were first subcultured on Sabouraud agar and incubated at 35
• C overnight and then transferred to a tube with saline (0.45% NaCl) to prepare a homogeneous fungal suspension with turbidity ranging from 1.8 to 2.2. Then, 280-μl aliquots of each fungal inoculum were transferred to a tube containing 3 ml of saline (0.45% NaCl). Finally, the tube was attached to the antifungal susceptibility card (AST-YS07) of the VITEK 2 TM system (Biomeriéux) and placed in the equipment. The strains C. parapsilosis ATCC R 22019 and C. krusei ATCC R 6258 were used as quality control, 19 as recommended by the manufacturer.
Investigation of resistance mechanisms
Rhodamine 6 G (R6G) acts as a substrate for efflux pumps, 20, 21 and therefore its fluorescence was used as a tool for the evaluation of efflux activity. The test was performed as described by Rocha et al. (2016) , 22 with modifications.
The azole-resistant strain and a susceptible strain of D. nepalensis were cultured in the presence (pre-exposition) or absence (negative control) of MIC/8 of fluconazole in triplicate in 5 ml YEPD broth and incubated at 37
• C overnight under agitation, allowing the growth to achieve a concentration of 2 × 10 7 cells/ml. After growth, the cells were centrifuged at 4500 g for 5 min, the supernatant was discarded, and the pellet washed twice in 2 ml phosphate-buffered saline (PBS, pH 7.0). Subsequently, cells were deprived of energy through incubation under constant shaking in 2 ml of PBS at 37
• C for 1 h. Then R6G was added to obtain a final concentration of 15 μmol/l, and the suspension was incubated at 37
• C for 1 h in the dark, under agitation, in order to allow R6G influx into yeast cells. After incubation, the cells were washed twice in 1 ml of cold PBS and resuspended in equal volume of cold PBS. An aliquot of 100 μl of the fungal suspension was resuspended in 2 ml PBS to obtain the inoculum, and 50 μl of the inoculum was transferred to 96-well plates previously prepared with 150 μl of PBS with and without glucose and allowed to rest for 5 minutes. The supernatant was removed and the fluorescence signal recorded at intervals of 1, 15, 30, and 60 minutes using the CFX96 TouchTM Real-Time PCR Detection System (Bio Rad, Hercules, California, USA), using 610-650 nm filter. The induced fluconazole-resistant strain of C. parapsilosis ATCC 22019 22 was used as quality control.
Besides analyzing the efflux activity of the resistant isolate, the ergosterol content of this strain was also assessed. For such, the azole-resistant strain and a susceptible strain of D. nepalensis were cultured in the presence (pre-exposition) or absence (negative control) of MIC/8 of fluconazole in triplicate in 5 ml YEPD broth and incubated at 37
• C overnight under agitation, allowing the growth to achieve a concentration of 2 × 10 7 cells/ml. Then the replicates were centrifuged at 9660 × g for 3 min. The pellets were washed in PBS and adjusted to the turbidity 2 on McFarland scale. Then 1 ml of the suspension was centrifuged at 9660 g for 3 min, and the pellet resuspended in 0.5 ml of alcohol-KOH solution (0.7 mol/l KOH in 60% ethanol) and incubated for 1 h at 95
• C in a water bath. After cooling, 0.6 ml of n-hexane was added, and the tubes were shaken vigorously for 5 min. Subsequently, the tubes were centrifuged at 13 416 × g for 1 min, and the upper organic layer transferred to a new tube and mixed with 1 ml of n-hexane. 
Results
Isolation and identification of yeasts
The isolation and identification results are shown in Table 1 . A total of 48 yeasts were identified with a higher number of isolates obtained from fecal samples (21/48), followed by samples from plant material (19/48) and cloacal samples (6/48). From the 30 samples of the first collection (cloaca = 10; stool = 10; plant = 10), 30 yeasts were recovered and identified: 7 Candida famata complex, 10 Candida nepalensis (n = 8, 3 from cloaca and 5 from feces), and C. palmioleophila (n = 4, 1 from cloaca, 1 from feces, and 2 from plant). No significant differences in recovery rate and recovered isolates between animal enclosures and sites of isolation were observed.
In vitro susceptibility testing of C. famata cryptic species and resistance mechanisms
Antifungal minimum inhibitory concentrations (MICs) against the 15 strains of C. famata are shown in Table 2 . MIC ranges obtained through broth microdilution (gold standard) were 0.25-2 μg/ml for amphotericin B, 0.03125-0.5 μg/ml for caspofungin, 0.5->64 μg/ml for fluconazole, <0.03125-4 μg/ml for voriconazole, and 0.03125-0.25 μg/ml for itraconazole. The MIC ranges obtained through the VITEK 2 TM system were 0.25-16, 0.25-0.5, 2->64, and ≤0.125-2 μg/ml for amphotericin, caspofungin, fluconazole, and voriconazole, respectively. Itraconazole was not evaluated through this automated system because it is not included in the antifungal susceptibility card of VITEK 2 TM .
High MICs were observed for amphotericin B against six strains isolated from the cloaca (two D. nepalensis) and feces (four D. nepalensis) of scarlet ibises, with 2/6 and 6/6 isolates classified as nonsusceptible through broth microdilution and VITEK 2 TM automated system, respectively. One of these nonsusceptible to amphotericin B D. nepalensis isolate was also classified as resistant to fluconazole and voriconazole by both methods. Moreover, resistance to caspofungin and itraconazole was not observed among these isolates. Overall, no significant differences were observed between the antifungal MIC values obtained through broth microdilution and those obtained through VITEK 2 TM automated system. However, when each drug was individually analyzed, VITEK 2 TM showed higher MIC values for amphotericin B (P = .038) and caspofungin (P = .006), with no significant differences observed for fluconazole and voriconazole. Finally, the overall comparison of the antifungal MICs against strains recovered from different sites showed no significant differences. However, when each drug was individually analyzed, higher voriconazole MICs were observed against strains recovered from cloaca, when compared to the MICs obtained against strains from plant material (P = .0310).
When the azole-resistant D. nepalensis was pre-exposed to fluconazole, an increase in the R6G efflux was observed, after 1 min of incubation with glucose, when compared to the fluconazole-unexposed control of this azole-resistant isolate, while this phenomenon was not observed for the tested azole susceptible isolate of D. nepalensis. As for the detection of total sterols, in spite of not having differences in the ergosterol content between azole-resistant and susceptible isolates, before and after exposure to fluconazole, an alteration in the profile of total sterols was observed between azole resistant and susceptible isolates, when the resistant isolate was exposed to fluconazole, which may indicate the production of other sterols.
Discussion
The microbiological aspects of captive scarlet ibises (E. ruber) is an understudied area of interest. In this study, yeasts were recovered from cloaca and feces of healthy individuals and from plant material collected in the environment where they live. The study of the yeast microbiota of clinically healthy wild birds is important, considering that birds may harbor potentially pathogenic yeast and contribute to the dissemination of these fungi in the environment, which may be a sanitary problem, especially for captive birds kept in collective enclosures.
1,2
Candida sp. is the most commonly recovered yeast genus from birds, regardless of the studied avian order. The species C. albicans, C. tropicalis, C. inconspicua, C. pelliculosa, C. famata, C. parapsilosis, and C. guilliermondii have been isolated from several domestic and wild birds, such as raptors, cockatiels, rheas, parrots, among others. [1] [2] [3] 23 In this research, feces and plant had higher recovery rates than the cloaca, which was the isolation site with the lowest recovery rate, as previously reported. 2, 3, 23 This difference may be associated with greater microbial colonization, as feces and plant material are exposed to external environmental microorganisms, while the environment within the cloaca is more controlled, with a limited amount of nutritional resources. Therefore, a greater microbial competition is likely observed in the cloaca than in the other isolation sites. Moreover, birds have high core body temperature, around 39-40 o C, which can limit yeast growth, as several species are thermosensitive. It was also observed that the recovery rate of C. famata and closely related species from feces (30%; 6/20), and plant material (25%; 5/20) tended to be higher than that from cloaca (20%; 4/20), suggesting that, even though these species are observed as a component of the cloacal microbiota of scarlet ibises, they are also present in their environment, contributing for further colonization of fecal samples. These findings suggest that stools are an important source of environmental contamination, possibly for providing good nutritional support for yeast growth.
In humans, C. famata has been described in bloodstream infections, associated with the use of catheters, peritonitis, and mediastinitis. However, it is a rare cause of candidiasis, accounting for 0.2-2% of the isolates collected in studies on antifungal resistance. 24, 25 High antifungal MICs have been described and are a concern, especially, when C. famata is causing invasive candidiasis. 24, 25 Nowadays, it is known that the phenotypical species previously known as C. famata is now considered a species complex, 17 Afterward, the susceptibility to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole of the isolated C. famata was evaluated through broth microdilution. One isolate of D. nepalensis recovered from stools was simultaneously resistant to fluconazole and voriconazole and presented a reduced susceptibility to amphotericin B. Additionally, one isolate of D. nepalensis from cloacal swab also presented reduced susceptibility to amphotericin B. Interestingly, high antifungal MICs were only observed against isolates from cloacal or fecal samples but not against those recovered from plants. Considering resistance to azoles is commonly associated with alterations in gene sequence or expression, especially the overexpression of efflux pumps, as a result of selective pressures induced by the environmental exposure to azole antifungals of clinical and/or agricultural use, 3,27-31 our findings suggest that scarlet ibises in captivity may be suffering antifungal selective pressures. These pressures possibly contribute for the induction of antifungal resistance among yeasts from the microbiota of these birds. Furthermore, even though high amphotericin B MICs (>1 μg/ml) were observed against strains from cloaca and feces of scarlet ibises through both techniques, the MICs obtained through VITEK 2 TM were statistically higher than those obtained through broth microdilution. Similar results were observed in the study of Kathuria et al. (2015) 32 , who reported high amphotericin B MICs (≥8 μg/ml) against 99% of the isolates tested through VITEK 2 TM , whereas high MICs were observed against 4.4% of the isolates when broth microdilution was applied. This discrepancy between MICs obtained through VITEK 2 TM and broth microdilution is likely associated with the methodology used by the automated system. VITEK 2 TM evaluates the effect of three antifungal concentrations on fungal growth, and the MIC value is inferred according to the curve of growth inhibition. In this research, high amphotericin B MICs obtained through VITEK 2 TM (MIC≥4 μg/ml) were mostly associated with higher MICs obtained through microdilution (MICs of 1 or 2 μg/ml). Therefore, as previously stated, 32, 33 this automated system may be a useful screening method for detecting the emergence of decreased amphotericin B susceptibility among strains of Candida spp., including C. famata and closely related species, even though they are not included in the antifungal susceptibility data bank of VITEK 2 TM .
The emergence of resistance to amphotericin B in strains of Candida spp. is rare, 27, 34 which is usually caused by the decrease in the amount of ergosterol in plasma membrane or lipid abnormalities, leading to a diminished binding of amphotericin B to the plasma membrane. 27, 30 However, intrinsically high amphotericin B MICs have been reported among isolates of C. krusei, C. glabrata, and C. lusitaniae. 27, 35 Regarding the analysis of resistance mechanisms, the significant difference in the R6G efflux observed between pre-exposed and unexposed samples after 1 min incubation may be associated with the immediate activation of efflux pumps, as a result of the pre-exposure of the resistant isolate of D. nepalensis to fluconazole. Furthermore, the quantification of total sterols demonstrated an alteration in the profile of total sterols between azole resistant and susceptible isolates, when the resistant isolate was exposed to fluconazole. This finding suggests that fluconazole may trigger the synthesis of other sterols, most likely as a mechanism of salvaging the cell membrane from the effects of azole drugs and amphotericin B.
In conclusion, scarlet ibises and their environment harbor C. famata and closely related species, including antifungal resistant isolates, emphasizing the need of monitoring the antifungal susceptibility of these yeast species.
